2020
DOI: 10.1016/j.nmd.2020.11.009
|View full text |Cite
|
Sign up to set email alerts
|

The 2021 version of the gene table of neuromuscular disorders (nuclear genome)

Abstract: General features This table is published annually in the December issue. Its purpose is to provide the reader of Neuromuscular Disorders with an updated list of monogenic neuromuscular diseases due to a primary defect residing in the nuclear genome. It comprises diseases in which the causative gene is known or at least localized on a chromosome, if not yet identified. Diseases for which the locus has not been mapped or which are due to defects involving mitochondrial genes are not included. 1 As in past years … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
53
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 53 publications
(55 citation statements)
references
References 0 publications
2
53
0
Order By: Relevance
“…We demonstrated the utility of a tissue atlas for monogenic disease biology, where we inferred the primary and secondary pathobiology of monogenic muscle diseases by analyzing skeletal, cardiac and smooth muscle. Disease groups were enriched not only for genes expressed in myocytes, but also for non-myocytes, including nervous system, immune and stromal cells (Benarroch et al, 2020). Note that we observed multiple subtypes of myocytes within one tissue, including cytoplasmic myocytes (high myoglobin (MB) expression and exon:intron ratio), which suggests possible specialization of different nuclei in one syncytium.…”
Section: Discussionmentioning
confidence: 73%
See 1 more Smart Citation
“…We demonstrated the utility of a tissue atlas for monogenic disease biology, where we inferred the primary and secondary pathobiology of monogenic muscle diseases by analyzing skeletal, cardiac and smooth muscle. Disease groups were enriched not only for genes expressed in myocytes, but also for non-myocytes, including nervous system, immune and stromal cells (Benarroch et al, 2020). Note that we observed multiple subtypes of myocytes within one tissue, including cytoplasmic myocytes (high myoglobin (MB) expression and exon:intron ratio), which suggests possible specialization of different nuclei in one syncytium.…”
Section: Discussionmentioning
confidence: 73%
“…While human genetics has successfully identified many rare monogenic disease genes, the cell type(s) of action are often unknown, or can even be incorrect, as shown for CFTR, the gene underlying cystic fibrosis (Montoro et al, 2018;Plasschaert et al, 2018). Leveraging the three muscle types in our atlas-cardiac, skeletal muscle, and smooth muscle-we sought to identify the cell type(s) of action for a broad group of well-curated monogenic muscle disease genes (Benarroch et al, 2020) (Table S6). We tested the subset of genes for each disease group (e.g., hereditary cardiomyopathies, motor neuron diseases) for enrichment in cell type-specific markers from our muscle tissues (FDR < 0.1) (Methods, Figure 4A).…”
Section: Genes From Monogenic Muscle Disease Groups Are Enriched In Distinct Subsets Of Myocyte and Non-myocyte Cells In Cardiac Skeletalmentioning
confidence: 99%
“…Induced ER stress, including increased PERK signaling, was observed in skeletal muscle biopsy samples from myotonic dystrophy 1 patients and in mdx mice, a model of Duchenne muscular dystrophy (Hulmi et al, 2016; Ikezoe et al, 2007). Moreover, mutations in genes coding for aminoacyl-tRNA synthetases are implicated in human neuromuscular disorders (Benarroch et al, 2020), and autoantibodies against aminoacyl-tRNA synthetases are found in autoimmune disease (Targoff et al, 1993). Collectively, downstream genes of hnRNPK are strongly associated with neuromuscular and other disorders in humans, suggesting that targeting hnRNPK to regulate the expression of these genes and signaling may become a new therapeutic strategy for human diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Motor neuron disease (MND) represents a wide and expanding group of different neurological disorders resulting from isolated or combined involvement of lower and upper motor neurons. The main adult-onset clinical disorder in this group is amyotrophic lateral sclerosis (ALS) 1 , however there is a high number of sporadic and hereditary neurological diseases that may present with MND phenotype and should be considered in the differential diagnosis (Table 1) 2,3,4 .…”
Section: Introductionmentioning
confidence: 99%